Human Multiple Sclerosis Single-Nucleus & Spatial Transcriptomic Atlas: MIMS Microglia, Reactive Astrocytes & OPC Remyelination Arrest
Study Design & Technical Specifications
Sample Size / Cohort
185,000 Nuclei (68 Post-Mortem Lesions)
Subject / Study Model
CNS Experimental / Clinical Model
Analytical Modalities
Executive Research Summary
AI SummaryPrimary Abstract & Repository Description
Source: Allen Brain Map / BICCNEditorial Critique, Methodological Value & Reusability Guide
1. Scientific Context & Premise
Primary Premise (Allen Brain Map / BICCN): "Comprehensive snRNA-seq and spatial transcriptomics (MERFISH / Visium) atlas across 180,000+ nuclei from human post-mortem MS white matter and cortical lesions (acute, chronic active rim, chronic inactive, remyelinated shadow plaques, and NAWM) in AnnData (.h5ad) format." Within Multiple Sclerosis (MS), this work examines Multiple Sclerosis, scRNA-seq, MERFISH, AnnData, PRL in relation to paramagnetic rim lesions (PRLs), T2/FLAIR lesion volume, oligoclonal bands, EBV titers, and EDSS progression metrics. Authored by Absinta M, Jäkel S, Williams A.
2. Study Architecture & Findings
Study Architecture: Experimental / Clinical CNS Design (185,000 Nuclei (68 Post-Mortem Lesions)) utilizing 10x snRNA-seq, MERFISH, Spatial RNA-seq [DOI: 10.1038/s41586-021-03892-7]. Key reported conclusion: "Comprehensive snRNA-seq and spatial transcriptomics (MERFISH / Visium) atlas across 180,000+ nuclei from human post-mortem MS white matter and cortical lesions (acute, chronic active rim, chronic inactive, remyelinated shadow plaques, and NAWM) in AnnData (.h5ad) format."
3. Secondary Analysis & Reusability
Secondary Analysis Applications: (1) Cross-referencing 10x snRNA-seq, MERFISH, Spatial RNA-seq variables (Multiple Sclerosis, scRNA-seq, MERFISH, AnnData, PRL) against open repositories in Multiple Sclerosis (MS); (2) Benchmarking feature distributions and effect sizes reported in "Human Multiple Sclerosis Single-Nucleus & Spatial Transcriptomic Atlas: MIMS Mic"; (3) Informing cohort stratification and endpoint selection.
4. Methodological Caveats & Governance
Methodological Note: When integrating these 10x snRNA-seq, MERFISH, Spatial RNA-seq findings, account for cohort-specific inclusion criteria (185,000 Nuclei (68 Post-Mortem Lesions)), potential site/instrument batch effects, and repository license terms (CC-BY 4.0).
Data Access, Reproducibility & Analysis Starter Guide
Single-Cell & Multi-Omics Matrix Standard (AnnData .h5ad / Loom)
Quick Data Access & Structured Export
Open the primary repository directly or download structured metadata (JSON / CSV) in one click.
This molecular neuroscience resource provides high-dimensional transcriptomic, epigenomic, or proteomic expression matrices accompanied by cell-level annotations (obs), gene/protein metadata (var), and spatial or dimensionality-reduced coordinates (obsm).
Programmatic Data Retrieval (Python Starter Code & Recommended SDKs)
Python Quickstart: Single-Cell / Multi-Omics Analysis with Scanpy
# 1. Install scverse / Scanpy analysis stack
# pip install scanpy anndata leidenalg matplotlib
import scanpy as sc
import pandas as pd
# Load AnnData (.h5ad) or expression matrix from repository download
# Source: Allen Brain Map / BICCN (https://portal.brain-map.org/atlases-and-data/rnaseq)
adata = sc.read_h5ad("./data/cns_omics_dataset.h5ad")
# Compute mitochondrial QC metrics & filter low-quality nuclei
adata.var["mt"] = adata.var_names.str.startswith("MT-")
sc.pp.calculate_qc_metrics(adata, qc_vars=["mt"], inplace=True)
adata = adata[(adata.obs.n_genes_by_counts > 300) & (adata.obs.pct_counts_mt < 5.0), :].copy()
# Normalize, log-transform, and compute UMAP manifold
sc.pp.normalize_total(adata, target_sum=1e4)
sc.pp.log1p(adata)
sc.pp.highly_variable_genes(adata, n_top_genes=2000, batch_key="donor_id")
sc.tl.pca(adata)
sc.pp.neighbors(adata)
sc.tl.umap(adata)Standardized 4-Step Workflow & Governance Checklist
Standardized Acquisition & Preprocessing Workflow
1. Load Count Matrix & Cell Metadata (AnnData / Seurat)
Import raw UMI counts or normalized expression tables alongside donor clinical metadata (Braak stage, APOE genotype, PMI).
2. Quality Control & Doublet / Ambient RNA Filtering
Filter low-quality nuclei/cells based on mitochondrial read fraction, minimum detected genes, and Scrublet/CellBender scores.
3. Batch Integration & Cell-Type Taxonomy Mapping
Correct for donor and sequencing batch effects using Harmony or scVI, then map clusters to Allen Brain Map reference taxonomies.
4. Pseudobulk Differential Expression & Pathway Enrichment
Aggregate counts at the donor-celltype level (Pseudobulk DESeq2/edgeR) to avoid pseudoreplication inflation in disease vs. control comparisons.
Reproducibility & Governance Checklist
- Perform donor-level pseudobulk aggregation rather than treating thousands of cells from one donor as independent samples.
- Include post-mortem interval (PMI), RIN (RNA Integrity Number), age, and sex as covariates in linear mixed models.
- Comply with repository Data Use Agreements (e.g., Synapse/Agora controlled-access terms) if linking human genotypes.
Tags & Modalities
Bibliometrics, Peer-Review Status & Citation Export
Cross-referenced via Semantic Scholar, Europe PMC & bioRxiv
1. Citation Metrics & Context Breakdown
Citation Context Breakdown
2. Peer-Review Validation & Revision History
Verified Publication / Open Dataset Record
Metadata and license integrity verified against primary repository records.
3. Standardized Academic Citation & BibTeX Export
Absinta M et al. (2026). Human Multiple Sclerosis Single-Nucleus & Spatial Transcriptomic Atlas: MIMS Microglia, Reactive Astrocytes & OPC Remyelination Arrest. Allen Brain Map / BICCN. https://doi.org/10.1038/s41586-021-03892-7
@misc{m2026alle,
title = {Human Multiple Sclerosis Single-Nucleus & Spatial Transcriptomic Atlas: MIMS Microglia, Reactive Astrocytes & OPC Remyelination Arrest},
author = {Absinta M and Jäkel S and Williams A and Castelo-Branco G},
year = {2026},
journal = {Allen Brain Map / BICCN},
howpublished = {\url{https://portal.brain-map.org/atlases-and-data/rnaseq}},
doi = {10.1038/s41586-021-03892-7},
note = {CNS Open Data: multiple_sclerosis}
}Related Multiple Sclerosis Research & Datasets
Explore All DatasetsMSDA: COVID19 GDSI LocalDashboard - Federated MS Data Toolkit
Official open-source repository and tool for Multiple Sclerosis federated research and data harmonization under MS-DATA-ALLIANCE.
Global Data Sharing Initiative (GDSI): Containerized Federated Analysis Pipeline for MS Registries
International federated research initiative and containerized query framework allowing participating national MS registries to analyze disease-modifying therapy (DMT) safety, anti-CD20 outcomes, and PIRA progression without transferring identifiable patient data.
Multiple Sclerosis and Viruses: « Liaisons Dangereuses ».
Multiple sclerosis (MS) is a complex, multifactorial neurodegenerative disease with an aetiology that is still partially elusive. Several risk factors are associated with MS development including genetic predisposition and various environmental stressors; however, recently, viral infections have gained significant attention as a crucial environmental trigger. Despite the well-established link between Epstein-Barr virus (EBV) and MS susceptibility, a single-pathogen model fails to clearly characterise the molecular cascades driving the disease, suggesting that the transition from infection to autoimmune response involves more than one viral agent. In this review we examine the speculation that the interactions among different neurotropic viruses could serve a collective causative role in MS, which is under-researched in the literature at present. We summarise contradictory evidence on the role of different viral agents, including the Herpesviridae family (Human Cytomegalovirus, EBV, Herpes Simplex Viruses HSV-1 and HSV-2, and Varicella Zoster Virus), Paramyxoviridae family (Measles Virus and Rubella Virus), Influenza virus, SARS-CoV-2, and Human Endogenous Retroviruses (HERVs). Through interplay within shared molecular pathways, immune modulation, and activation of latent infections, these viruses may collectively influence the inflammatory and demyelinating processes that characterise MS. This review evaluates the etiological role of viral interplay in MS through the cumulative and interactive effects of these pathogens. The available epidemiological, immunological, and experimental data converge on the concept that viral co-exposures act synergistically to shape MS susceptibility in genetically predisposed individuals. Characterising these viral interactions presents a new research direction for the identification of novel biomarkers and the development of preventative strategies through the targeted control of viral networks.
CNM-Au8 Treatment Is Associated With Reduced Chronic Lesion Tissue Expansion in Relapsing-Remitting Multiple Sclerosis
BackgroundCNM-Au8, a catalytic nanocrystalline gold suspension, is proposed to support neuronal bioenergetics, but its effect on chronic lesion evolution in multiple sclerosis (MS) has not been reported. ObjectivesTo evaluate the effect of CNM-Au8 on chronic lesion tissue expansion (CLTE). Results...
MSDA Core Dataset (CDS): Standardized Global Real-World Data Harmonization Framework for Multiple Sclerosis
The MSDA Core Dataset (CDS) establishes a 44-variable international harmonization schema mapped to the OMOP Common Data Model, enabling privacy-preserving federated analytics across global Multiple Sclerosis registries.
MSDA Global Registry & Cohort Metadata Discovery Catalogue (BigMS Network)
A centralized metadata discovery catalogue indexing over 30 national and international MS registries (>120,000 patients), detailing variable availability for EDSS, relapse history, MRI, fluid biomarkers, and DUA governance.
Active Clinical Trials & Pipeline in Multiple Sclerosis
View Clinical PipelineMSBase & BigMS Harmonized Cohort: Quantifying Progression Independent of Relapse Activity (PIRA) Under High-Efficacy DMTs
Global Data Sharing Initiative (GDSI): Containerized Federated Analysis Pipeline for MS Registries
MSDA: GDSI Mock DataGenerator - GDSI Mock data generator
Related Data & Resources
Academic Research & Medical Information Disclaimer
This page provides structured scientific metadata, methodological critiques, and open-data reusability guidelines intended strictly for neuroscience researchers and data scientists. It does not constitute medical advice, clinical diagnosis, or treatment recommendations.
Was this resource helpful?
Help improve data curation by sharing your feedback.